US 11236100
Modulators of eukaryotic initiation factor 2B, compositions and methods
granted A61KA61K31/415A61K31/4164
Quick answer
US patent 11236100 (Modulators of eukaryotic initiation factor 2B, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/415, A61K31/4164, A61K31/421, A61K31/4245